Model
Edge
Nektar Therapeutics
NKTR
Filing Type
S-8
Filing Date
11/11/2025
Updated
11/12/25, 2:17 PM
Filing
S-8
Earnings Release
Exhibits
S-8
Registration Statement for Securities to be Offered to Employees
EX-4.8
NEKTAR THERAPEUTICS 2025 INDUCEMENT PLAN AND FORMS OF STOCK OPTION AGREEMENT AND RESTRICTED STOCK UNIT AGREEMENT
EX-5.1
OPINION OF GOODWIN PROCTER LLP WITH RESPECT TO THE VALIDITY OF THE SECURITIES
EX-23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-FILING FEES
FILING FEE TABLE
GRAPHIC
Graphic